25 January 2025
BRC Announces Development and Regulatory Milestone Following Successful Type C CMC Meeting with FDA, Advancing Clinical Development of Multiple Therapeutic Candidates
» Full release
3 December 2024
BRC-002 receives Orphan Drug Designation from FDA for Complex Regional Pain Syndrome
» Full release
3 October 2024
Biopharmaceutical Research Company Announces First Dose of BRC-002, a First-in-Class Cannabinoid Therapeutic for Complex Regional Pain Syndrome (CRPS), in Investigator-Initiated Study
» Full release
12 September 2024
First patient received BRC-001, a cannabinoid therapeutic, in a clinical trial investigating supportive care in breast cancer at City of Hope
» Full release
12 January 2020
Clever Leaves Announces First Export of Dried Cannabis Flower to the United States
» Full release
